VJET Flyte Aviation, Inc.
Surgical & Medical Instruments & Apparatus · NYSE · SEC CIK 1716621 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY599.8%
TTM net income YoY-51.9%
TTM EPS YoY89.8%
Revenue 3-yr CAGR124.0%
Net income 3-yr CAGR—
Margins
Gross margin29.2%
Operating margin-527.1%
Net margin-733.4%
FCF margin-331.6%
EBITDA margin-499.9%
Returns
ROE-273.6%
ROA-104.1%
ROIC (approx.)-173.4%
Asset turnover0.14x
Leverage & solvency
Liabilities / assets51.7%
Debt / equity0.00x
Current ratio0.54x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.45x
Accruals ratio-57.1%
Payout ratio—
Capex / revenue0.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $819,000 | $420,000 |
| Cost of revenue | $63,000 | $42,000 |
| Gross profit | $756,000 | $378,000 |
| R&D expense | $862,000 | $272,000 |
| SG&A expense | $12.07M | $11.35M |
| Operating income | -$21.14M | -$11.24M |
| Pretax income | -$19.50M | -$13.50M |
| Income tax | -$1.81M | $3.14M |
| Net income | -$17.18M | -$16.64M |
| EBITDA | -$19.03M | -$9.13M |
| EPS (basic) | -15.90 | -126.91 |
| EPS (diluted) | — | — |
| Balance sheet | ||
| Cash & equivalents | $88,000 | $2.87M |
| Short-term investments | $0 | — |
| Receivables | $155,000 | $70,000 |
| Inventory | $86,000 | $33,000 |
| Current assets | $390,000 | $3.29M |
| PP&E, net | $0 | $91,000 |
| Goodwill | $0 | — |
| Intangibles | $0 | $24.27M |
| Total assets | $15.86M | $27.77M |
| Current liabilities | $3.91M | $2.23M |
| Short-term debt | $0 | — |
| Long-term debt | $3.08M | — |
| Total debt | $3.08M | — |
| Total liabilities | $9.21M | $16.01M |
| Shareholders' equity | $7.05M | $11.76M |
| Net debt | $2.99M | — |
| Shares outstanding | 173,896 | 421,296 |
| Cash flow statement | ||
| Operating cash flow | -$8.30M | -$9.27M |
| Capital expenditure | $17,000 | $67,000 |
| Free cash flow | -$8.31M | -$9.34M |
| Investing cash flow | $167,000 | -$67,000 |
| Financing cash flow | $5.34M | $8.65M |
| Depreciation & amortization | $2.12M | $2.11M |
| Stock-based compensation | $338,000 | $54,000 |
Free plan shows the latest 2 periods; Pro shows all 9 🔒
· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.